Fumiya Hongo

2.4k total citations
108 papers, 973 citations indexed

About

Fumiya Hongo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Fumiya Hongo has authored 108 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Pulmonary and Respiratory Medicine, 40 papers in Molecular Biology and 30 papers in Surgery. Recurrent topics in Fumiya Hongo's work include Renal cell carcinoma treatment (29 papers), Prostate Cancer Treatment and Research (24 papers) and Prostate Cancer Diagnosis and Treatment (21 papers). Fumiya Hongo is often cited by papers focused on Renal cell carcinoma treatment (29 papers), Prostate Cancer Treatment and Research (24 papers) and Prostate Cancer Diagnosis and Treatment (21 papers). Fumiya Hongo collaborates with scholars based in Japan, United States and Poland. Fumiya Hongo's co-authors include Tsuneharu Miki, Osamu Ukimura, Sara Huerta‐Yépez, Benjamin Bonavida, Takashi Ueda, Koji Okihara, Hermes Garbán, Mario I. Vega, Ali R. Jazirehi and Kazumi Kamoi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Fumiya Hongo

97 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumiya Hongo Japan 17 435 342 217 182 152 108 973
Marine Lefèvre France 18 314 0.7× 424 1.2× 291 1.3× 208 1.1× 214 1.4× 67 1.1k
Omar Y. Mian United States 19 385 0.9× 269 0.8× 200 0.9× 172 0.9× 108 0.7× 85 907
Sadafumi Kawamura Japan 19 292 0.7× 529 1.5× 143 0.7× 152 0.8× 144 0.9× 68 887
Olivier Giger United Kingdom 16 357 0.8× 279 0.8× 244 1.1× 164 0.9× 158 1.0× 34 1.0k
Liyi Xie China 16 345 0.8× 222 0.6× 239 1.1× 276 1.5× 232 1.5× 54 1.1k
Qingfang Li China 17 437 1.0× 222 0.6× 336 1.5× 235 1.3× 102 0.7× 37 1.0k
Norihito Soga Japan 16 611 1.4× 460 1.3× 277 1.3× 129 0.7× 214 1.4× 68 1.2k
Naritaka Tanaka Japan 21 467 1.1× 362 1.1× 273 1.3× 251 1.4× 437 2.9× 58 1.1k
Michihiko Tajiri Japan 20 352 0.8× 600 1.8× 348 1.6× 203 1.1× 140 0.9× 72 1.1k

Countries citing papers authored by Fumiya Hongo

Since Specialization
Citations

This map shows the geographic impact of Fumiya Hongo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiya Hongo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiya Hongo more than expected).

Fields of papers citing papers by Fumiya Hongo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiya Hongo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiya Hongo. The network helps show where Fumiya Hongo may publish in the future.

Co-authorship network of co-authors of Fumiya Hongo

This figure shows the co-authorship network connecting the top 25 collaborators of Fumiya Hongo. A scholar is included among the top collaborators of Fumiya Hongo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiya Hongo. Fumiya Hongo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tsujimoto, Masashi, Yumiko Saito, Masatomo Kaneko, et al.. (2025). MRI‐Determined Tumor Contact Area as a Predictor of Pathological Extraprostatic Extension in Clinical T2 Prostate Cancer. PubMed. 2025(1). 9165949–9165949.
3.
Yamazaki, Hideya, Gen Suzuki, Koji Masui, et al.. (2024). The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy. Scientific Reports. 14(1). 8011–8011. 1 indexed citations
4.
Kato, Taigo, Junya Furukawa, Nobuyuki Hinata, et al.. (2024). Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study. International Journal of Clinical Oncology. 30(1). 99–109. 2 indexed citations
5.
6.
Naitoh, Yasuyuki, et al.. (2023). Factors affecting testicular volume after orchiopexy for undescended testes. Journal of Medical Ultrasonics. 50(4). 493–499. 1 indexed citations
7.
8.
Naitoh, Yasuyuki, et al.. (2021). Robot‐assisted laparoscopic pyeloplasty for ureteropelvic junction obstruction due to aberrant blood vessel with ipsilateral retrocaval ureter. SHILAP Revista de lepidopterología. 4(5). 273–276. 3 indexed citations
9.
Nakajima, Nobuyuki, Akira Miyajima, Nobuo Shinohara, et al.. (2021). Risk factors for recurrence after operation in patients with pT1a renal cell carcinoma: sub-analysis of the multi-institutional national database of the Japanese Urological Association. Japanese Journal of Clinical Oncology. 52(3). 274–280. 3 indexed citations
10.
Ito, Saya, Takeshi Nomura, Takashi Ueda, et al.. (2021). Gene expression profiles during tissue remodeling following bladder outlet obstruction. Scientific Reports. 11(1). 13171–13171. 7 indexed citations
11.
Matsugasumi, Toru, Takumi Shiraishi, Atsuko Fujihara, et al.. (2020). Targeted Focal Cryoablation for Prostate Cancer With Real-time Transrectal Ultrasound-guided Free-hands Technique: A Step-by-step Technique. Urology. 144. 261–262. 2 indexed citations
12.
Yamada, Yasuhiro, Akihisa Ueno, Masatomo Kaneko, et al.. (2019). Phase I study of cancer lesion-targeted microwave coagulation therapy for localized prostate cancer: A pilot clinical study protocol. Contemporary Clinical Trials Communications. 16. 100471–100471. 7 indexed citations
13.
Miura, Yuji, Chiyo K. Imamura, Keita Uchino, et al.. (2018). Individualized Dosing of Axitinib Based on First-Dose Area Under the Concentration–Time Curve for Metastatic Renal-Cell Carcinoma. Clinical Genitourinary Cancer. 17(1). e1–e11. 6 indexed citations
14.
Hagiwara, Nobuhisa, Motoki Watanabe, Isao Yokota, et al.. (2018). Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma. Cancer Letters. 431. 182–189. 20 indexed citations
15.
NAKAGAWA, Hideo, Takashi Ueda, Saya Ito, et al.. (2016). Androgen suppresses testicular cancer cell growthin vitroandin vivo. Oncotarget. 7(23). 35224–35232. 15 indexed citations
16.
Naya, Yoshio, Terukazu Nakamura, Masakatsu Oishi, et al.. (2015). The efficacy of radio-frequency ablation for metastatic lung or liver tumors of male germ cell tumors as an alternative minimally invasive therapy after salvage chemotherapy. International Journal of Clinical Oncology. 20(6). 1192–1197. 1 indexed citations
17.
Ueda, Takashi, Saya Ito, Takumi Shiraishi, et al.. (2015). PAX2 promoted prostate cancer cell invasion through transcriptional regulation of HGF in an in vitro model. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(11). 2467–2473. 5 indexed citations
18.
Naya, Yoshio, Akihiro Kawauchi, Takashi Ueda, et al.. (2014). Comparison of diameter-axial-polar nephrometry and RENAL nephrometry score for treatment decision-making in patients with small renal mass. International Journal of Clinical Oncology. 20(2). 358–361. 10 indexed citations
19.
Takaha, Natsuki, Takashi Ueda, Yasunori Kimura, et al.. (2012). Significance of serum tumor necrosis factor-related apoptosis-inducing ligand as a prognostic biomarker for renal cell carcinoma. Molecular and Clinical Oncology. 1(1). 69–74. 14 indexed citations
20.
Hongo, Fumiya, Sara Huerta‐Yépez, Hong‐Jeng Yu, et al.. (2005). Overexpression of inhibitor of apoptosis protein XIAP in human prostate cancer. Cancer Research. 65. 993–993. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marine Lefèvre Breakdown of academic impact, for papers by Omar Y. Mian Breakdown of academic impact, for papers by Sadafumi Kawamura Breakdown of academic impact, for papers by Olivier Giger Breakdown of academic impact, for papers by Liyi Xie Breakdown of academic impact, for papers by Qingfang Li Breakdown of academic impact, for papers by Norihito Soga Breakdown of academic impact, for papers by Naritaka Tanaka Breakdown of academic impact, for papers by Michihiko Tajiri
Rankless by CCL
2026